RADIUS HEALTH INC's ticker is RDUS and the CUSIP is 750469207. A total of 128 filers reported holding RADIUS HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $986,000 | +17.4% | 95,100 | 0.0% | 0.00% | – |
| Q1 2022 | $840,000 | +38.2% | 95,100 | +8.2% | 0.00% | – |
| Q4 2021 | $608,000 | -44.3% | 87,900 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,091,000 | -31.9% | 87,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,603,000 | -27.8% | 87,900 | -17.4% | 0.00% | 0.0% |
| Q1 2021 | $2,220,000 | +18.3% | 106,400 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $1,877,000 | +57.5% | 105,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,192,000 | -15.2% | 105,100 | +1.9% | 0.00% | 0.0% |
| Q2 2020 | $1,405,000 | +27.0% | 103,100 | +21.2% | 0.00% | 0.0% |
| Q1 2020 | $1,106,000 | -34.5% | 85,100 | +1.6% | 0.00% | -50.0% |
| Q4 2019 | $1,689,000 | -20.2% | 83,800 | +1.9% | 0.00% | 0.0% |
| Q3 2019 | $2,117,000 | +8.0% | 82,200 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $1,961,000 | +39.5% | 80,500 | +14.2% | 0.00% | 0.0% |
| Q1 2019 | $1,406,000 | +24.6% | 70,500 | +3.1% | 0.00% | +100.0% |
| Q4 2018 | $1,128,000 | -4.0% | 68,400 | +3.6% | 0.00% | 0.0% |
| Q3 2018 | $1,175,000 | -39.6% | 66,000 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $1,945,000 | -5.1% | 66,000 | +15.8% | 0.00% | 0.0% |
| Q1 2018 | $2,049,000 | +19.4% | 57,000 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $1,716,000 | -17.6% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,082,000 | -14.7% | 54,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $2,442,000 | +27.1% | 54,000 | +8.7% | 0.00% | +50.0% |
| Q1 2017 | $1,921,000 | +3.7% | 49,700 | +2.1% | 0.00% | -33.3% |
| Q4 2016 | $1,852,000 | -29.7% | 48,700 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $2,634,000 | +47.5% | 48,700 | +0.2% | 0.00% | +33.3% |
| Q2 2016 | $1,786,000 | +32.0% | 48,600 | +9.0% | 0.00% | +50.0% |
| Q1 2016 | $1,353,000 | -39.1% | 44,600 | +23.5% | 0.00% | -60.0% |
| Q4 2015 | $2,222,000 | -9.7% | 36,100 | +1.7% | 0.01% | -16.7% |
| Q3 2015 | $2,461,000 | +46.6% | 35,500 | +43.1% | 0.01% | +50.0% |
| Q2 2015 | $1,679,000 | +147.3% | 24,800 | +50.3% | 0.00% | +100.0% |
| Q1 2015 | $679,000 | +80.1% | 16,500 | +70.1% | 0.00% | +100.0% |
| Q4 2014 | $377,000 | – | 9,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 645,417 | $12,869,615 | 3.75% |
| Rubric Capital Management LP | 1,992,078 | $39,722,000 | 3.71% |
| BB BIOTECH AG | 6,781,685 | $135,227,000 | 3.40% |
| HealthCor Management, L.P. | 3,680,949 | $73,398,000 | 2.96% |
| Congress Park Capital LLC | 81,342 | $1,622,000 | 1.40% |
| Rock Springs Capital Management LP | 1,175,000 | $23,430,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 105,829 | $2,109,000 | 0.78% |
| Spark Investment Management LLC | 677,800 | $13,515,000 | 0.62% |
| KNOTT DAVID M | 77,269 | $1,541,000 | 0.61% |
| DAFNA Capital Management LLC | 42,000 | $837,000 | 0.36% |